Quantcast

Latest Retinitis pigmentosa Stories

2008-09-03 09:00:46

LINCOLN, R.I., Sept. 3 /PRNewswire/ -- Neurotech Pharmaceuticals, Inc., a privately-held biotechnology company focused on the development of sight-saving therapeutics for chronic retinal diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designations for NT-501 for the treatment of visual loss in two indications -- retinitis pigmentosa (RP) and the dry form of age-related macular degeneration (dry AMD). NT-501 is an intraocular, cell containing...

2008-08-14 15:00:59

Pipex Pharmaceuticals, Inc. (AMEX: PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of central nervous system (CNS) and autoimmune diseases, today announced its clinical update and results for its second quarter of 2008. A conference call has been scheduled for 4:30 p.m. EDT today. In order to participate in the conference call, please call toll free: 888-256-9124 and international dial-in: 913-312-0830. A replay of the conference...

2008-06-30 15:03:02

Case Western Reserve University School of Medicine, in collaboration with Copernicus Therapeutics, Inc. and Polgenix, Inc., was selected to receive $3.9 million in funding from the Ohio Biomedical Research Commercialization Program (BRCP) as awarded by Lieutenant Governor Lee Fisher, Chair of the Ohio Third Frontier Commission. The BRCP awards grants that support Ohio-based biomedical and biotechnology research leading to commercialization and long-term improvements to the health of...

0673e82cfc6fdf0b5674da1904dd87691
2008-04-21 12:10:00

Two blind patients in Britain became the first new owners of an artificial electronic retinal device last week.Surgeons at Moorfields Eye Hospital in London successfully transplanted the bionic eye, which uses a video camera and transmitter mounted on a pair of glasses.The artificial retina enables patients to discriminate rudimentary images of motion, light and dark.The operations were carried out by Mr Lyndon da Cruz, a consultant retinal surgeon, and his team from the Vitreo Retinal...

2008-04-03 18:00:42

IRVINE, Calif., April 3, 2008 (PRIME NEWSWIRE) -- Vitreoretinal Technologies, Inc. (VRT) today announced the enrollment of the first patients in a multinational Phase III clinical trial for evaluation of the safety and efficacy of VRT's investigational drug Vitreosolve(r) for diabetic retinopathy patients. The first patients were enrolled and treated at clinical sites both in the U.S. and India. Vitreoretinal Technologies (VRT) is a specialty pharmaceutical company with a specific focus on...

591b3cb758fbd87c4713b32c4e431f0d1
2008-03-18 15:55:00

New hope for regenerating the human retina damaged by disease or injuryScientists at Schepens Eye Research Institute have discovered what chemical in the eye triggers the dormant capacity of certain non-neuronal cells to transform into progenitor cells, a stem-like cell that can generate new retinal cells. The discovery, published in the March issue of Investigative Ophthalmology and Visual Science (IOVS), offers new hope to victims of diseases that harm the retina, such as macular...

2007-06-04 12:00:42

Copernicus Therapeutics, Inc. announced today that a research team at University of Oklahoma Health Sciences Center, led by Dr. Muna Naash, Professor of Cell Biology, demonstrated that Copernicus' DNA nanoparticles corrected vision defects in a mouse model of retinitis pigmentosa (RP). These findings were presented at the American Society of Gene Therapy meeting in Seattle, WA. Mutations in genes important in the biology of vision cause RP, a common genetic form of visual impairment...

2006-10-25 12:01:04

Optobionics Corporation, a developer of innovative medical devices for the treatment of vision loss due to degenerative retinal diseases, today provided an update on the interim results from its multi-center, pilot clinical study of the Artificial Silicon Retina (ASR®) device. Results from the 20 patients treated with the ASR device show measurable vision improvement in a significant number of Retinitis Pigmentosa patients. These patients currently have no treatment...

2005-08-03 15:09:44

GAINESVILLE, Fla. - University of Florida scientists used a healthy human gene to prevent blindness in mice with a form of an incurable eye disease that strikes boys. Writing in the August issue of Molecular Therapy, scientists from the UF Genetics Institute describe how they successfully used gene therapy in mice to treat retinoschisis, a rare genetic disorder that is passed from mothers, who retain their sight, to their sons. "Currently there is no treatment," said William Hauswirth,...

e6459d01c870d2de4d1a4ddd44a9d6ae1
2005-05-08 11:30:00

Device allows formerly blind patients to see, identify objects HealthDay News -- An "artificial retina" is helping six previously blind patients detect light, identify objects and perceive motion, researchers announced Friday. "If you project a long, 2-foot bar of light on a projector, they can tell which way the light bar moves, right or left, up or down. They can detect motion," said lead researcher Dr. Mark Humayun, an ophthalmology professor at the University of Southern California's...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'